Total Payments
$6,400
2024 Payments
$984.14
Companies
21
Transactions
363
Medicare Patients
12,044
Medicare Billing
$502,885
Payment Breakdown by Category
Food & Beverage$5,348 (83.6%)
Travel$789.14 (12.3%)
Education$262.59 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,348 | 351 | 83.6% |
| Travel and Lodging | $789.14 | 2 | 12.3% |
| Education | $262.59 | 10 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,259 | 69 | $0 (2024) |
| Abbott Laboratories | $1,081 | 17 | $0 (2024) |
| PFIZER INC. | $1,027 | 83 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $653.04 | 50 | $0 (2022) |
| Amgen Inc. | $493.58 | 32 | $0 (2024) |
| Merck Sharp & Dohme LLC | $476.33 | 28 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $258.49 | 8 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $249.64 | 20 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $195.39 | 16 | $0 (2024) |
| iRhythm Technologies, Inc. | $177.44 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $984.14 | 55 | Novartis Pharmaceuticals Corporation ($340.47) |
| 2023 | $1,079 | 66 | Novartis Pharmaceuticals Corporation ($284.71) |
| 2022 | $665.94 | 44 | Merck Sharp & Dohme LLC ($221.71) |
| 2021 | $329.12 | 22 | Janssen Pharmaceuticals, Inc ($74.41) |
| 2020 | $242.72 | 12 | AstraZeneca Pharmaceuticals LP ($99.99) |
| 2019 | $636.23 | 47 | Novartis Pharmaceuticals Corporation ($201.14) |
| 2018 | $812.23 | 54 | Janssen Pharmaceuticals, Inc ($215.93) |
| 2017 | $1,651 | 63 | Abbott Laboratories ($880.74) |
All Payment Transactions
363 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/16/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: CDS - Holter Monitoring_RM | ||||||
| 10/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Cardiology | ||||||
| 10/07/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/07/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/05/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.30 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/27/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.29 | General |
| Category: Cardiovascular | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiology | ||||||
| 08/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.44 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardiology | ||||||
| 07/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,331 | 3,078 | $314,524 | $104,788 |
| 2022 | 27 | 2,804 | 3,669 | $323,869 | $110,891 |
| 2021 | 30 | 3,171 | 4,062 | $379,007 | $134,546 |
| 2020 | 33 | 3,738 | 4,602 | $420,873 | $152,661 |
Total Patients
12,044
Total Services
15,411
Medicare Billing
$502,885
Procedure Codes
126
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 193 | $46,899 | $16,358 | 34.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 301 | 305 | $52,155 | $14,177 | 27.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 92 | 170 | $23,290 | $10,125 | 43.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 90 | 90 | $28,620 | $9,439 | 33.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 160 | 160 | $27,200 | $8,400 | 30.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 63 | $16,317 | $6,318 | 38.7% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 15 | 15 | $16,845 | $5,894 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 99 | $17,028 | $5,328 | 31.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 483 | 739 | $14,780 | $4,249 | 28.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 66 | 193 | $11,387 | $4,141 | 36.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 67 | 190 | $7,980 | $2,835 | 35.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 22 | $4,378 | $2,020 | 46.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $5,306 | $1,874 | 35.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 177 | 203 | $7,511 | $1,839 | 24.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 36 | 48 | $3,600 | $1,687 | 46.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 166 | 166 | $5,312 | $1,614 | 30.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 19 | 19 | $4,864 | $1,476 | 30.3% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 14 | 18 | $3,744 | $1,404 | 37.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 27 | 33 | $3,390 | $1,143 | 33.7% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 53 | 65 | $3,335 | $1,066 | 32.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 33 | 37 | $2,183 | $678.52 | 31.1% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 34 | 35 | $1,820 | $638.08 | 35.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 35 | 35 | $1,750 | $569.18 | 32.5% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 14 | 16 | $832.00 | $259.22 | 31.2% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 29 | 29 | $754.00 | $247.95 | 32.9% |
About Dr. Pramod Reddy, MD
Dr. Pramod Reddy, MD is a Cardiovascular Disease healthcare provider based in Corbin, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063417996.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pramod Reddy, MD has received a total of $6,400 in payments from pharmaceutical and medical device companies, with $984.14 received in 2024. These payments were reported across 363 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($5,348).
As a Medicare-enrolled provider, Reddy has provided services to 12,044 Medicare beneficiaries, totaling 15,411 services with total Medicare billing of $502,885. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Corbin, KY
- Active Since 06/16/2005
- Last Updated 12/08/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063417996
Products in Payments
- CardioMEMS HF System (Device) $884.83
- ENTRESTO (Drug) $704.57
- ELIQUIS (Drug) $701.84
- XARELTO (Drug) $653.04
- LEQVIO (Drug) $554.25
- VERQUVO (Drug) $476.33
- Corlanor (Drug) $318.46
- BRILINTA (Drug) $242.55
- LifeVest (Device) $195.39
- VYNDAQEL (Drug) $187.44
- PRADAXA (Drug) $178.82
- CHANTIX (Drug) $165.27
- Repatha (Biological) $165.12
- ZIO XT Patch (Device) $152.01
- Inpefa (Drug) $86.95
- JARDIANCE (Drug) $70.82
- CARDIOMEMS (Device) $66.70
- BodyGuardian (Device) $62.11
- CAMZYOS (Drug) $57.03
- PRALUENT (Drug) $54.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Corbin
Khalid Chaudry, M.d, M.D
Cardiovascular Disease — Payments: $2,470
Cardiovascular Disease $2,470
Anantha Krishna, M.d, M.D
Cardiovascular Disease — Payments: $1,803
Cardiovascular Disease $1,803
Luna Khanal, Md, MD
Cardiovascular Disease — Payments: $1,162
Cardiovascular Disease $1,162
Dr. John Loventhal, Md, MD
Cardiovascular Disease — Payments: $29.77
Cardiovascular Disease $29.77